$2.710
-0.010 (-0.37%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CMMB Prediction & Forecast by Similar Chart Analysis
Alphio's CMMB stock price prediction model matches the current Chemomab Therapeutics Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.70 (-0.27%). The 1-week path is $2.82 (+4.00%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Chemomab Therapeutics Ltd Stock?
Chemomab Therapeutics Ltd (CMMB) is a good buy right now due to its recent price increase of 25.46% over the last 5 days and a strong RSI of 94.74, suggesting momentum. The company is also preparing for a Phase 3 trial for its lead drug candidate, which could significantly enhance its market position. However, the main risk is its negative net income, which was -2,165,000 USD in Q2 2026, indicating ongoing financial losses.
CMMB stock price ended at $2.71 on Friday, after losing -0.37%
Chemomab Therapeutics Ltd (CMMB) last closed at $2.71, losing -0.37%. These facts feed the 1-day and 1-week CMMB price prediction above.
Forecast Drivers
Chemomab Therapeutics Ltd (CMMB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
Similar Chart Patterns
Stocks whose recent price path most closely matches CMMB, ranked by similarity.
Seasonality analysis for CMMB
Historically the probability of a positive August return for CMMB is 61.90%. August offers the highest probability of a positive month at 61.90%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CMMB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $1.28 | $1.35 | $1.39 | -50.17% |
| Sep 2026 | $1.12 | $1.16 | $1.32 | -57.27% |
| Oct 2026 | $1.05 | $1.11 | $1.19 | -58.95% |
| Nov 2026 | $1.06 | $1.07 | $1.13 | -60.58% |
| Dec 2026 | $1.01 | $1.21 | $1.23 | -55.44% |
In 2026, Chemomab Therapeutics Ltd (CMMB) is projected to range from $1.01 to $1.39.
Chemomab Therapeutics Ltd 2026 monthly forecast
In Aug 2026, Chemomab Therapeutics Ltd is projected to average $1.35, with a low of $1.28 and high of $1.39.
In Sep 2026, Chemomab Therapeutics Ltd is projected to average $1.16, with a low of $1.12 and high of $1.32.
In Oct 2026, Chemomab Therapeutics Ltd is projected to average $1.11, with a low of $1.05 and high of $1.19.
In Nov 2026, Chemomab Therapeutics Ltd is projected to average $1.07, with a low of $1.06 and high of $1.13.
In Dec 2026, Chemomab Therapeutics Ltd is projected to average $1.21, with a low of $1.01 and high of $1.23.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.